MBII - Marrone Bio Innovations Inc. (MBII) CEO Kevin Helash on Q4 2020 Results - Earnings Call Transcript
Marrone Bio Innovations, Inc. (MBII) Q4 2020 Earnings Conference Call March 23, 2021 04:30 PM ET Company Participants Linda Moore - General Counsel Kevin Helash - Chief Executive Officer Sue Cheung - Chief Financial Officer Conference Call Participants Bobby Burleson - Canaccord Laurence Alexander - Jefferies Sameer Joshi - H.C. Wainwright Nathan Weinstein - Aegis Capital Steven Ralston - Zacks Presentation Operator Good day, and welcome to the Marrone Bio Innovations Fourth Quarter 2020 Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Linda Moore, General Counsel. Linda Moore Good afternoon, everyone, and thank you for joining our call. Welcome to the 2020 fourth quarter and full year earnings conference call for Marrone Bio Innovations. On the call today are CEO, Kevin Helash; and CFO, Sue Cheung. If you would please refer to slide two, I would like call
For further details see:
Marrone Bio Innovations, Inc. (MBII) CEO Kevin Helash on Q4 2020 Results - Earnings Call Transcript